Researchers have a new battle tactic to fight drug-resistant bacterial infections. Their strategy involves using collections of bacteriophages, viruses that naturally attack bacteria.
coli—responsible for most UTIs—is able to use host nutrients to reproduce at an extraordinarily rapid ... The findings, Mobley notes, open avenues for the development of new therapeutics—which is ...
The Food and Drug Administration (FDA) has approved amoxicillin to treat specific bacterial infection of the ears, nose, throat, the urinary tract, the skin, and the lower respiratory tract. The drug ...